4
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of the Combination of Carboplatin and Cyclophosphamide in the Treatment of Metastatic Insulinoma

&
Pages 523-524 | Published online: 11 Jun 2009

References

  • Fajans S S, Vinik A I. Insulin-producing islet cell tumors. Endocrin Metab Clin North Am 1989; 18: 45–74
  • Boden G. Glucagonomas and insulinomas. Gastroenterol Clin North Am 1989; 18: 831–845
  • Eriksson B, Skogseid B, Lundquist G. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 1990; 65: 1883–1890
  • Longnecker S M. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide. Drug Intell Clin Pharm 1988; 22(2)136–138
  • Stehouwer C D, Lems W F, Fischer H R. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue more effective than single therapy with either drug. Neth J Med 1989; 35(1–2)86–94
  • Moertel C G, Hanley J A, Johnson L A. Streptozocin alone compared with streptozocin plus flourouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 1980; 303: 1189–1194
  • Dt Kiang, Frenning D H, Bauer G E. Mithramycin for hypoglycemia in malignant insulinoma. N Engl J Med 1978; 299: 134–135
  • Eastman R C, Come S E, Strewler G J. Adriamycin therapy for advanced insulinoma. J Clin Endocr Metab 1977; 44: 142–148

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.